^ abPetrova, Mariya I.; Lievens, Elke; Malik, Shweta; Imholz, Nicole; Lebeer, Sarah (2015). “Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health”. Front. Physiol.6. doi:10.3389/fphys.2015.00081. ISSN1664-042X.
^ ab“Review article: fungal microbiota and digestive diseases”. Aliment. Pharmacol. Ther.39 (8): 751–766. (April 2014). doi:10.1111/apt.12665. PMID24612332. "In addition, GI fungal infection is reported even among those patients with normal immune status. Digestive system-related fungal infections may be induced by both commensal opportunistic fungi and exogenous pathogenic fungi. ... In vitro, bacterial hydrogen peroxide or organic acids can inhibit C. albicans growth and virulence61 In vivo, Lactobacillus sp. can inhibit the GI colonisation and infection of C. albicans62 In vivo, C. albicans can suppress Lactobacillus sp. regeneration in the GI tract after antibiotic therapy63, 64"
^ ab“Small intestinal fungal overgrowth”. Curr Gastroenterol Rep17 (4): 16. (April 2015). doi:10.1007/s11894-015-0436-2. PMID25786900. "Small intestinal fungal overgrowth (SIFO) is characterized by the presence of excessive number of fungal organisms in the small intestine associated with gastrointestinal (GI) symptoms. Candidiasis is known to cause GI symptoms particularly in immunocompromised patients or those receiving steroids or antibiotics. However, only recently, there is emerging literature that an overgrowth of fungus in the small intestine of non-immunocompromised subjects may cause unexplained GI symptoms. ... Fungal-bacterial interaction may act in different ways and may either be synergistic or antagonistic or symbiotic . Some bacteria such as Lactobacillus species can interact and inhibit both the virulence and growth of Candida species in the gut by producing hydrogen peroxide . Any damage to the mucosal barrier or disruption of GI microbiota with chemotherapy or antibiotic use, inflammatory processes, activation of immune molecules and disruption of epithelial repair may all cause fungal overgrowth ."
^ abFord, Alexander C; Quigley, Eamonn M M; Lacy, Brian E; Lembo, Anthony J; Saito, Yuri A; Schiller, Lawrence R; Soffer, Edy E; Spiegel, Brennan M R et al. (2014). “Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis”. The American Journal of Gastroenterology109 (10): 1547–1561. doi:10.1038/ajg.2014.202. ISSN0002-9270. PMID25070051.
^Baucells, B.J.; Mercadal Hally, M.; Álvarez Sánchez, A.T.; Figueras Aloy, J. (2015). “Asociaciones de probióticos para la prevención de la enterocolitis necrosante y la reducción de la sepsis tardía y la mortalidad neonatal en recién nacidos pretérmino de menos de 1.500g: una revisión sistemática”. Anales de Pediatría. doi:10.1016/j.anpedi.2015.07.038. ISSN1695-4033.
^Inglin, Raffael C. (2015). “High-throughput screening assays for antibacterial and antifungal activities of Lactobacillus species”. Journal of Microbiological Methods114 (July 2015): 26–29. doi:10.1016/j.mimet.2015.04.011.